Secondary cancers following allogeneic haematopoietic cell transplantation in adults. - Wikidata - awgldk - TriplyDB

Secondary cancers following allogeneic haematopoietic cell transplantation in adults.

Secondary cancers following allogeneic haematopoietic cell transplantation in adults.

http://www.wikidata.org/entity/Q37880254

about

Next-generation long-term transplant clinics: improving resource utilization and the quality of care through health information technology Glioblastoma Multiforme in a Post Allogeneic Stem Cell Transplant Patient. A Case Report and Literature Review of Post Transplant Neurological Tumors Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning Long-term follow-up after allogeneic stem cell transplantation Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study.Prevalence of hematopoietic cell transplant survivors in the United States.Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.Long-term complications after hematopoietic cell transplantation.Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry.Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.Donor-Cell Origin High-Risk Myelodysplastic Syndrome Synchronous with an Intracranial Meningioma-Like Tumor, 8 Years after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.Donor-derived mycosis fungoides following reduced intensity haematopoietic stem cell transplantation from a matched unrelated donor.[Delayed effects of oncological therapy].Inverse correlation of Vδ2+ T-cell recovery with EBV reactivation after haematopoietic stem cell transplantation.Subsequent malignancies after allogeneic hematopoietic stem cell transplantation.Provision of long-term monitoring and late effects services following adult allogeneic haematopoietic stem cell transplant: a survey of UK NHS-based programmes.Multiple skin cancers in a patient within 1 year of allogeneic haematopoietic cell transplant for chronic lymphocytic leukaemia.Sezary syndrome manifesting as posttransplant lymphoproliferative disorder.

P2860

Q26787225-CBA0596E-E1BB-435C-AFD5-44141ED1C642 Q30355135-29F5D6D2-A901-471F-8B52-21296F9FB1A4 Q34325244-13090E5C-9C22-4B4C-BA06-D7E9E13E1B7C Q35104794-3D8B6E5F-0154-4F56-B62E-4873264CCC3C Q35677669-3E0FD8B3-6820-45C6-99E7-8E5BDC805307 Q37188807-F7B5FAFC-9691-4C52-956D-03A79AD95F89 Q38628809-6D1A0862-9D57-42FE-8545-2E5F674EC8FF Q38667959-A3EBEFD3-CFBE-4A5C-A24F-533066922742 Q38729286-B7A02E74-C0A7-487C-90AB-7581CDE4416D Q38798042-8D602429-9AB4-426D-B7AB-552C003AE625 Q41439610-36E397CC-D612-4CD2-933F-326FA73047BF Q42087799-49D1F264-D7DD-4FFB-992E-E9E93EBB6490 Q44239233-1D6D0FC5-1E60-4B30-ABDF-4FE6A540AFC7 Q47261859-E8F7414C-5C31-4D52-97C3-3EB8A0F044A4 Q48245233-B729BF31-0550-417A-BBDC-3FF5F5ECE4D5 Q48660711-7EB26363-C62A-4A42-B07B-8D5579ADF51A Q52966828-E2445CA7-06CC-4436-9E6D-F7D471D64C55 Q55214705-32BA284A-2BF9-4745-94E0-BD0312AEB145

P2860

Secondary cancers following allogeneic haematopoietic cell transplantation in adults.

http://www.wikidata.org/entity/Q37880254

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Secondary cancers following allogeneic haematopoietic cell transplantation in adults.

@en

Secondary cancers following allogeneic haematopoietic cell transplantation in adults.

@nl

type

label

Secondary cancers following allogeneic haematopoietic cell transplantation in adults.

@en

Secondary cancers following allogeneic haematopoietic cell transplantation in adults.

@nl

prefLabel

Secondary cancers following allogeneic haematopoietic cell transplantation in adults.

@en

Secondary cancers following allogeneic haematopoietic cell transplantation in adults.

@nl

P1433

Q37880254-4711C988-873E-4D0F-9640-51481FA377E5

P1476

Q37880254-55D215DB-42F5-47B0-994A-D727648D49ED

P2093

Q37880254-EA90DB47-95EB-4FDD-AF16-34D8CABA7D35

P2860

Q37880254-0270DEA0-4FE2-4FBC-9D3D-989A28D618C0

Q37880254-034F34AE-C20A-42D8-8C17-7307B9A23846

Q37880254-108A0086-F4C0-424E-9B7F-8FA1BB49F3DB

Q37880254-150F00EB-51AD-43D9-B4B1-CDBE3F58F027

Q37880254-18D63CF6-BF59-4FE2-B0FE-065DD7536410

Q37880254-1F5A7982-5ADC-4AD9-B980-93D8A67A0620

Q37880254-3DAC0C4E-2082-4F96-BF01-C48449DE5D2A

Q37880254-3E1E2F8D-3CA7-47ED-B3CB-829D97AD1016

Q37880254-438BB2C1-B217-4681-A4E9-EAAC0DE964EA

Q37880254-4490D77E-2EB2-471D-AE6A-D492B885CE5F

P304

Q37880254-32090DDD-FB8B-490D-B74C-AFDA6C496287

P31

Q37880254-428C5FDB-9F19-4120-B255-6A60734FAEC0

P356

Q37880254-09B1DD23-3BAA-4F51-A412-40BFF101DE77

P407

Q37880254-6B31D9EC-FFC7-4C90-A9AA-F9DDB6E9A514

P433

Q37880254-EE7B3B5C-D24C-4720-8F89-0EF510F3696E

P478

Q37880254-46112519-1F50-42DC-9A00-6BFBBD0BDA88

P577

Q37880254-41DFE7C6-566F-435C-A83E-22DAC8AF77C2

P5875

Q37880254-A830F5E4-12B5-4B54-A11D-D2484F86F664

P698

Q37880254-A5EA3348-498D-4CA3-8FE6-A9F172B3F08A

P356

J.1365-2141.2011.08756.X

P1433

British Journal of Haematology

P1476

Secondary cancers following allogeneic haematopoietic cell transplantation in adults.

@en

P2093

Navneet S Majhail

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation.

Frequent genomic alterations in epithelium measured by microsatellite instability following allogeneic hematopoietic cell transplantation in humans.

Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.

Donor-derived second hematologic malignancies after cord blood transplantation.

Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation

Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination.

Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study

P304

301-310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2011.08756.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

154

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51168274

http://www.w3.org/2001/XMLSchema#string

P698

21615719

http://www.w3.org/2001/XMLSchema#string